Morgan Cheatham
Vice President @ Bessemer Venture Partners
New York, United States
Morgan Cheatham is a seed investor at Bessemer Venture Partners in New York focused on Medical and Biopharma. Morgan Cheatham is the Head of health care and life sciences of Breyer Capital. Morgan Cheatham joined Bessemer Venture Partners in 2017 as an investor in the New York City office where he focuses on machine intelligence, healthcare, financial technology, and enterprise software.Before joining Bessemer, Morgan worked at Goldman Sachs in theConsumer Retail and Healthcare Group in the Investment Banking Division. He also worked as a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management.Morgan graduated magna cum laude from Brown University with a Bachelor of Science in Neuroeconomics in the Liberal Medical Education Program. At Brown, he launched a retail investing app called Fello, which enables investors to create investment clubs with peers from their social networks. In his free time, Morgan enjoys practicing Tae Kwon Do, exploring the NYC music scene, and going to brunch.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Morgan Cheatham invests in
Stages Morgan Cheatham invests in
Countries Morgan Cheatham invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (25%)
- Biopharma 2 (25%)
- Health Care 2 (25%)
- LGBT 1 (13%)
- Wellness 1 (13%)
Stage
- Seed 3 (38%)
- Series A 1 (13%)
- Series B 1 (13%)
- Funding Round 1 (13%)
- Venture - Series Unknown 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Network Bio is a clinical and molecular data library enabling precision medicine approaches for common human diseases. Its platform delivers a centralized repository for clinical and molecular data that allows researchers to identify patterns and correlations that can be used to develop new treatments and diagnostic tools. | $50M / Venture - Series Unknown / Aug 19, 2026 | ||
| Pathway Labs is a cardiology AI company. Its EchoNext software is an FDA cleared multi condition tool. It analyzes standard 12 lead ECGs to detect structural heart disease. The platform integrates into clinical workflows to coordinate patient care. | $8.5M / Seed / Jun 23, 2026 | ||
| ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | $13M / Seed / May 07, 2026 | ||
| Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $30M / Series B / Oct 12, 2022 | ||
| Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $25M / Series A / Feb 02, 2021 | ||
| Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $4.4M / Seed / Dec 03, 2020 | ||
| Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | Apr 21, 2020 | ||
| Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. |
Co-Investors
Bessemer Venture Partners is a venture capital firm that invests in early-stage and growth-stage companies across technology, healthcare, and consumer sectors. It provides capital to startups and emerging businesses while supporting founders with strategic guidance, operational insight, and network access. The firm participates in multiple funding stages, from seed investments to later growth rounds, and works closely with portfolio companies on product development, market expansion, and organizational scaling. Its investment activities span software, cloud infrastructure, fintech, biotech, and internet-enabled businesses, aligning capital deployment with long-term company building.
Bessemer Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aia Sarycheva
Investor
|
|||
Alexandra Sukin
Investor
|
|||
Anant Vidur Puri
Partner
|
|||
Andrew Hedin
Partner
|
|||
Caty Rae
Investor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Morgan Cheatham invest in?
Morgan Cheatham invests primarily in Medical, Biopharma and Health Care startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Morgan Cheatham?
Public channels for Morgan Cheatham include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Morgan Cheatham last invest?
The most recent investment recorded for Morgan Cheatham closed in Aug 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
